New developments in acne;L'acne aujourd'hui: Quoi de neuf?

Presse Medicale

Volumn 29, Issue 19, 2000, Pages 1091-1097

  Auffret, N ^a  

^a Service de Dermatologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI ACNE AGENT; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; ISOTRETINOIN; RETINOID; DERMATOLOGICAL AGENT; KERATOLYTIC AGENT;

ACNE; DISEASE SEVERITY; DRUG CONTRAINDICATION; HUMAN; PREGNANCY; REVIEW; TREATMENT PLANNING; ACNE VULGARIS; ADOLESCENT; ADULT; FEMALE; INTRADERMAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; MALE; PATIENT COMPLIANCE; PREGNANCY; RETINOIDS;

EID: 0034720616     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Aizawa H, Nakada N, Nimura M. Androgen status in adolescents women with acne vulgaris. J Dermatol 1995 ; 22:530-2.
2. Schmidt JB, Spona J, Huber J. Androgen receptor in hirsutism and acne. Cynecol Obstet Invest 1986 ; 22:206-11.
3. Aizawa H, Nimura M, Elevated insulin-like growth factor 1 (IGF) levels in women with postadolescent acne. J Dermatol 1995 ; 22:249-52.
4. Guy R, Green, MR, Kealy T. Modelling acne in vitro. J Invest Dermatol 1993 ; 128:242-8.
5. Knaggs H, Holland K, Morris C. Quantification of cellular proliferation in acne using the monoclonal a monoclonal antibody Ki 67. J Invest Dermatol 1994 ; 102:89-2.
6. Kanaar P. Follicular-keratogenic properties of fatty acis in the external canal of the rabbit. Dermatologica 1971 ; 142:14-22.
7. Strauss Downing DT, Stewart ME, Wertz PW. Essential fatty acids and acne. J Am Acad Dermatol 1986 ; 14:221-5.
8. Thiboutot D, Knaggs H, Gilliland K, Lin G. Activity of 5 alpha reductase and 17 beta hydroxysteroid in the infrainfundibulum of subjects with and without acne vulgaris. Dermatologica 1998 ; 22:38-42.
9. Guy R, Kealy T. Dermatology 1998 ; 196 : 32-37
10. Ingham E, eady A, Goodwin CE, Cove JH, Cunliffe WJ. Pro-inflammatory levels of interleukin 1alpha like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992 ; 98:895-901.
11. Böhm M, Luger Th. The pilosebaceous unit is part of the skin immune system. Dermatology 1998 ; 196:75-9.
12. Holland KT, Aldana O, Bojar RA et al. Propionibacterium acnes and acne. Dermatology 1998 ; 22:97-8.
13. Webster GF. Inflammation in acne vulgaris. J Am Acad Dermatol 1995 ; 32:247-53.
14. Shalita A R. Clinical aspects of acne. Dermatology 1998 ; 196:93-4.
15. Lucky A. A review of infantile and pediatric acne. Dermatology 1998 ; 196:95-7.
16. Layton AM, Knaggs H, Taykor J, cunliffe WJ. Isotretinoin for acne vulgaris. 10 years later a safe and successful treatment. Br J Dermatol 1993 ; 129:292-6.
17. Choi EH, Bang D. Acne fulminans and 13-cis retinoic acid. J Dermatol 1992 ; 19:378-83.
18. Plewig G, Jansen T. Aneiform dermatoses. Dermatologica 1998 ; 196:102-7.
19. Leyden JJ, Marples RR, Mills OH, Kligman AM, Gram negative folliculitis. A complication of antibiotic therapy in acne vulgaris. Br J Dermatol 1973, 88:533-8.
20. Panconesi E, Hautman G. Psychotherapeutic approach in acne treatment. Dermatologica 1998 ; 22:116-??
21. Strauss JS. Sebaceous gland, acne and related disorders. An epilogue. Dermatologica 1998 ; 22:182-4.
22. Gollnick H, Vogt K, Hermann J, Blume U, Hahn H, Haustein UF, Orfanos CE. Topical quinolone OPC 7251 : a clinical and microboliogical stuy in acne. Eur J Dermatol 1994 ; 4:210-15.
23. Gollnick H, Schramm M. Topical drug treatment in Acne. Dermatologica 1998 ; 22: 19-25.
24. Jick SS, Terris BZ, Jick H. First trimester topical Tretinoin and congenital disorders. Lancet 1993 ; 341:1181-2.
25. Nau H. Embryotoxicity and teratogenicity of topical retinoid acid. Skin Pharmacol 1993 ; 6:35-44.
26. Meffert H, Gaunitz K, Gutewort T, Amlong UJ/ Aknetherapie mit sichtbarem Schutz. Dermatol Monatsschr 1990 ; 176:597-603.
27. Ghyczy M, Nissen HP, Blitz H. The treatment of acne vulgaris by phophatidylcholine from soybeans, with a high content of linoleic acid. J Appl Cosmetol 1996 ; 14:137-45.
28. Messina M. Oral and topical spironolactone in skin androgenization. Panminerva Med 1990 ; 32:49-55.
29. Goulden V, Glass D, Cunlifte JR: long term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol 1994 ; 131:360-3.
30. Layton AM, Cunliffe WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol 1992 ; 27:S2-7.
31. Lehucher-Ceyrac D, Weber-Buisset MJ. Isotretinoin and acne in practice. a prospective analysis of 188 cases over 9 years. Dermatology 1993 ; 129:292-6.
32. Eady EA, Jones CE, Gardner KJ, Taylor JP, Cove JH, Cunliffe WJ. Tetracyline-resistant prionibacteria from acne patients are cross resistant to doxycycline, but sensitive to minocycline. Br J Dermatol 1993 ; 128:556-60.
33. Orfanos CE, Zouboulis CH. Oral retinoids in the treatment of seborrhea and acne. Dermatologica 1998 ; 22:140-7.
34. Cunliffe WJ Acne London Dunitz 1989 ; p 391 .
35. Cunliffe WJ,55 th Am Acad Dermatol San Francisco, 1997.
36. Beylot C, Doutre MS, Beylot-Barye M. Oral contraceptives and cyproterone acetate in female acne treatment. Dermatologica 1998 ; 22:148-52.
37. th annu Meet Am Acad Dermatol, San Francisco 1997, poster 24.
38. Charpentier B, Bernadon JM, Eustache J et al. Syntheses, strcture-affinity relation ships and biological activities of ligans binding to retinoic acid receptor subtypes? J Med Chem 1995 ; 38:4993-5006.